Oren Ilan bought ROIV
September 16, 2026 · Form 4 insider transaction
Oren Ilan bought 5,054 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,054
Price
$0.00
Total value
N/A
InsiderOren Ilan
RoleDirector
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateSeptember 16, 2026
Filing dateSeptember 18, 2026
Shares owned after123,680
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.